CBLL Stock Summary and Trading Ideas (Ceribell | NASDAQ:CBLL)

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Ceribell trades on the NASDAQ stock market under the symbol CBLL.

As of October 30, 2026, CBLL stock price declined to $26.58 with 573,630 million shares trading.

CBLL has a beta of 0.42, meaning it tends to be less sensitive to market movements. CBLL has a correlation of 0.01 to the broad based SPY ETF.

CBLL has a market cap of $1.02 billion. This is considered a Small Cap stock.

Last quarter Ceribell reported $28 million in Revenue and -$.51 earnings per share. This beat revenue expectation by $828,576 and missed earnings estimates by -$.05.

The top ETF exchange traded funds that CBLL belongs to (by Net Assets): VTI, IWM, IWO, VXF, VTWO.

CBLL has outperformed the market in the last year with a price return of +134.8% while the SPY ETF gained +12.3%. CBLL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +50.7% and +6.2%, respectively, while the SPY returned +2.1% and -1.0%, respectively.

CBLL support price is $26.76 and resistance is $28.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBLL shares will trade within this expected range on the day.